NDC 55135-132 – Trodelvy

Sacituzumab Govitecan 180 mg/1 · Powder, For Solution · Intravenous

Human Prescription Drug

Product NDC55135-132

Product details

Brand name
Trodelvy
Generic name
Sacituzumab Govitecan
Labeler
Gilead Sciences, Inc.
Dosage form
Powder, For Solution
Route
Intravenous
Marketing category
BLA · BLA761115
Marketed since
April 22, 2020
Listing expires
December 31, 2027

Active ingredients

Uses, dosage, side effects and warnings for Trodelvy →

Package NDC codes (1)

Package NDCDescriptionSince
55135-132-011 VIAL in 1 BOX (55135-132-01) / 1 POWDER, FOR SOLUTION in 1 VIALApr 23, 2020